Skip to content Skip to footer

TOP 20

Top 20 Biopharma Deal Terminations of 2022 Based on Total Deal Value
Top 20 Biopharma Deal Terminations of 2022 Based on Total Deal Value
Shots: Post M&A deals, companies often cannot sail through a few key aspects of the partnership, such as limited ownership, exorbitant recovery costs, and poor integration process, leading to deal terminations. The improperly executed expansion program also contributes significantly to the failed partnership To tackle such scenarios, companies are cautious enough to make backup plans beforehand…
Twenty Women Leaders In Healthcare Industry
Twenty Women Leaders In Healthcare Industry
Shots: Trailblazing, inspiring, and emancipating, women’s contribution to society is highly significant. By breaking the shackles of orthodox social customs, they made an indistinguishable place in society that we all should be proud of Every year on the 8th of March, the world celebrates International Women’s Day as a day of observance for women’s triumph in the social,…
Radiopharma Top 20 2022
Top 20 Radiopharma Companies Based on Market Cap
Shots: Integrating scintigraphy with therapeutics, radiopharmaceutical companies have emerged profoundly in the past few decades. With the growing influence of radiopharmaceutical companies in oncology, the companies hold a firm grasp on the market With the expanding acceptance among HCPs, patients, and researchers, radiopharmaceutical companies are estimated to touch the $7.5B threshold by 2026. This year,…
Life Sciences Top 20 2022
Top 20 Life Sciences Deals of 2022 by Total Deal Value
Shots: The technological advancement, shared cost, and the pursuit of combined extensive research are amongst the few pragmatic and mutual benefits that come with collaborations. Moreover, the risks involved in drug development plans get minimalized by opening the doors to new opportunities and commercialization When it comes to life science collaborations, companies seek beyond the…
Ipo in Healthcare Top 20 2021
Top 20 IPOs in Healthcare by Total Fund Value
Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Apart from the exposure and capital raise, companies gain more recognition, credibility, and indispensable value assessment 2022 had been a great year when it comes to the IPOs of healthcare companies. Bausch…
Biopharma M&A Top 20 2022
Top 20 Biopharma M&A of 2022 by Total Deal Value
Shots:  Mergers and Acquisitions are among the predominant elements of the Biopharma Industry. Owing to the repercussions of the Russia-Ukraine war and the ongoing COVID-19 pandemic, the IPOs, public markets, anti-trust law reforms by the US FTC, and M&As among others were relatively low in the biopharma sector in the year 2022  In the year…
Animal Health Based Top 20 2022
Top 20 Animal Health Companies Based on 2021 Total Revenue
Shots:  The Animal Health industry plays a vital role in safeguarding animal husbandry and has experienced an evolving change over the years from disease control and treatment activities to a complete healthcare provider  As the bond between owners and their animal companion strengthens, the Animal Health industry foresees an exponential growth in the near future.…
Prescription Drugs Top 20 2021
Top 20 Prescription Drugs Based on 2021 Total Revenue
Shots: The pharmaceutical companies have shown continual efforts towards developing enhanced and innovative treatment options to address the unmet needs of patients with disease eradication being the goal of developing these treatments Advancements in cellular and molecular biology have increased the possibilities for generating new pharmaceutical products imposing major impacts on the prevention, diagnosis, and…
Generic Companies Top 20 2021
Top 20 Generics Pharma Companies Based on 2021 Total Revenue
Shots: With an increased price range and the lack of accessibility of branded products, the generic version of these products has been established to be more affordable and accessible to patients, providers, and the healthcare system. Therefore, Generic medicines are a bioequivalent substitute for a marketed brand-name drug, developed after the expiry of the patent…
Oncology Top 20 2021
Top 20 Oncology Companies Based on 2021 Oncology Segment Total Revenue
Shots: Oncology focuses on the study, diagnosis, prevention, and treatment of cancer based on the treatment option and it’s divided into 3 major areas including medical oncology, radiation oncology, and surgical oncology The advancements in cell and gene therapies have provided pharmaceutical companies with a unique set of ground-breaking tools for the development of more…